TrialJAMA oncology2020

Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.

Amylou C Dueck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.